Tommy Freeman

Research group:
029 208 70141
Tower Building, Park Place

Research summary

Alzheimer's Disease is the leading cause of dementia and is charaterised by chronic neurodegeneration as well as the accumulations of β-amyloid "plaques" and tau "tangles". The aggregation of β-amyloid peptides was first proposed as the cause of the disease in 1991. However, we still have no disease modifying therapies.

My research aims to uncover a physiological role for the β-amyloid in normal cognition. We will use an antibody to inhibit its production, before analysing any effect on learning and memory. We will also utilise a novel murine model of the disease which more accurately represents the human condition.

Full list of publications



Wellcome Trust

Research group

Behavioural Neuroscience

Research collaborators

Professor Mark Good

Dr Emma Kidd (Pharmacy)

Dr Rhian Thomas (Pharmacy)

Undergraduate education

Master of Natural Sciences (Biomedical Science & Chemical Biology) 2011-2015: First Class Honours, University of Southampton

Postgraduate education

April 2016 - Present: Wellcome Trust 4 Year PhD in Integrative Neuroscience

Awards/external committees

June - August 2012 Wellcome Trust Vacation Scholarship, University of Southampton, Professor Peter Roach